Investing.com -- Jasper Therapeutics Inc (NASDAQ:JSPR) stock surged 17.4% in premarket trading Tuesday after the clinical-stage biotech company reported positive preliminary data from its ETESIAN ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback